Evidence map›Paper›PMID 26681542›Full record

ArticleInternational journal of cardiology2016

Overexpression myocardial inducible nitric oxide synthase exacerbates cardiac dysfunction and beta-adrenergic desensitization in experimental hypothyroidism.

Qun Shao, Heng-Jie Cheng, Michael F Callahan, Dalane W Kitzman, Wei-Min Li, Che Ping Cheng

Abstract read
In one paragraph

Article in International journal of cardiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Chronic CaThe Journal of pharmacology and experimental therapeutics · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Qun ShaoDepartment of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Heng-Jie ChengSection on Cardiovascular Medicine, Wake Forest School of Medicine Winston-Salem, North Carolina, United States; Wake Forest, Institute for Regenerative Medicine, Winston-Salem, North Carolina, United States.
Michael F CallahanDepartment of Orthopaedic Surgery, Wake Forest School of Medicine Winston-Salem, North Carolina, United States.
Dalane W KitzmanSection on Cardiovascular Medicine, Wake Forest School of Medicine Winston-Salem, North Carolina, United States.
Wei-Min LiDepartment of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address: liweimin_2009@163.com.
Che Ping ChengDepartment of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, China; Section on Cardiovascular Medicine, Wake Forest School of Medicine Winston-Salem, North Carolina, United States. Electronic address: ccheng@wakehealth.edu.
Wake Forest University · USFirst Affiliated Hospital of Harbin Medical University · CNHarbin Medical University · CN

Funding

New Molecular Target for Cardiac AgingR01AG049770 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI CHENG, HENG-JIE · 2015 to 2019
$1.6M
Beta3-Adrenergic Receptor &Progression to Heart FailureR01HL074318 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI CHENG, CHE-PING · 2003 to 2006
$1.3M
NHLBI NIH HHS HL074318NHLBI NIH HHS R01 HL074318NIA NIH HHS R01 AG049770
6 · The paper itself

Abstract

backgroundAltered nitric oxide synthase (NOS) has been implicated in the pathophysiology of heart failure (HF). Recent evidence links hypothyroidism to the pathology of HF. However, the precise mechanisms are incompletely understood. The alterations and functional effects of cardiac NOS in hypothyroidism are unknown. We tested the hypothesis that hypothyroidism increases cardiomyocyte inducible NOS (iNOS) expression, which plays an important role in hypothyroidism-induced depression of cardiomyocyte contractile properties, [Ca(2+)]i transient ([Ca(2+)]iT), and β-adrenergic hyporesponsiveness. METHODS AND

resultsWe simultaneously evaluated LV functional performance and compared myocyte three NOS, β-adrenergic receptors (AR) and SERCA2a expressions and assessed cardiomyocyte contractile and [Ca(2+)]iT responses to β-AR stimulation with and without pretreatment of iNOS inhibitor (1400 W, 10(-5)mol/L) in 26 controls and 26 rats with hypothyroidism induced by methimazole (~30 mg/kg/day for 8 weeks in the drinking water). Compared with controls, in hypothyroidism, total serum T3 and T4 were significantly reduced followed by significantly decreased LV contractility (EES) with increased LV time constant of relaxation. These LV abnormalities were accompanied by concomitant significant decreases in myocyte contraction (dL/dtmax), relaxation (dR/dtmax), and [Ca(2+)]iT. In hypothyroidism, isoproterenol (10(-8)M) produced significantly smaller increases in dL/dtmax, dR/dtmax and [Ca(2+)]iT. These changes were associated with decreased β1-AR and SERCA2a, but significantly increased iNOS. Moreover, only in hypothyroidism, pretreatment with iNOS inhibitor significantly improved basal and isoproterenol-stimulated myocyte contraction, relaxation and [Ca(2+)]iT.

conclusionsHypothyroidism produces intrinsic defects of LV myocyte force-generating capacity and relaxation with β-AR desensitization. Up-regulation of cardiomyocyte iNOS may promote progressive cardiac dysfunction in hypothyroidism.

Indexed as

Gene Expression Regulation, EnzymologicAdrenergic beta-AgonistsAnimalsHypothyroidismMaleMyocytes, CardiacNitric Oxide Synthase Type IIRatsRats, Sprague-DawleyReceptors, Adrenergic, betaVentricular Dysfunction, LeftAdrenergic beta-AgonistsNitric Oxide Synthase Type IINos2 protein, ratReceptors, Adrenergic, betaBeta-adrenergic receptor agonistsCalciumCellsNitric oxide synthaseThyroid hormone

Identifiers

PMID26681542
PMCPMC4698083
OpenAlexW2102747917

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.